PATENT CLAIM ANALYSIS

Application Number: 15768316
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "181000"]

Abstract:
The present invention provides a method of treatment of inflammatory disorder of the eye, said method comprising administering into the eye of a person in need thereof, an aqueous solution comprising difluprednate as the sole active ingredient at a concentration of 0.02% to 0.04% weight by volume in an aqueous vehicle, wherein the solution is free of oil and wherein the solution is administered twice-a-day. The present invention also provides an ophthalmic solution comprising a. therapeutically effective concentration of difluprednate, a crystal growth inhibitor and pharmaceutically acceptable amounts of a solubilizer comprising a mixture of i. quaternary ammonium compound and ii. polyethoxylated castor oil, b. in an aqueous vehicle. wherein the crystal growth inhibitor is polyvinyl alcohol or its derivatives.

Claim (Index 3):
The method as claimed in  claim 3 , wherein the inflammatory disorder of the eye is acute anterior uveitis or chronic uveitis.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.79452
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15006525', '14661295', '15946709', '15571986', '15866744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7441641309545204
- 35 USC 102 Novelty (BERT): 0.4857524193730553
- Combined Prediction Score: 0.718322959796374
- Mean Citation Score: 139.70156200000002
- Max Citation Score: 147.32837
- Similarity Product: 96.46150998384238

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test